Camgenium Expands NHS Access to Advanced, Risk-Adjusted Clinical Audit Analytics

Cambridge, UK, 26th February 2026 / Sciad Communications / Camgenium is pleased to announce that it now offers NHS hospitals flexible, risk‑adjusted clinical audit reports, making advanced AI‑powered performance insights more accessible than ever.

Camgenium’s detailed hospital clinical audit reports provide accurate and actionable insight into performance and trends through the analysis of individual patient records that have been risk-adjusted. Reports cover both surgical and medical specialties.

As part of a strategic restructuring of its medical analytics offering, Camgenium will now provide hospitals with the option to commission one‑off, bespoke clinical audit reports. This new approach is designed to give NHS organisations greater flexibility and easier access to high‑quality analytics without long‑term contractual commitments.

Camgenium’s AI-powered medical analytics reports for clinicians and managers compare performance over time against nationally derived benchmarks. This helps teams focus on areas where patient outcomes and cost efficiencies can be most improved.

Each report combines advanced analytics with expert medical interpretation and consultancy. Dr Michael Roberts, Camgenium’s Medical Advisor, provides clinical support and results interpretation. Dr Roberts joined Camgenium in 2025 and has over 15 years of experience as medical director in acute hospitals, including in an NHS acute trust. Camgenium brings 17 years of experience and expertise in medical-grade AI and software development to ensure reports are valid and relevant. 

“By offering flexible, one-off risk-adjusted clinical audit reports, we’re removing longstanding barriers that have prevented some NHS trusts from accessing high-quality analytics,” said Dr Philip Gaffney OBE, CEO and founder of Camgenium. “Hospitals shouldn’t need major contracts or complex procurement processes to gain the insights they need. This new approach ensures more clinicians and managers can benefit from advanced performance analysis, helping NHS teams make better decisions and focus improvement efforts where they matter most.”

Key benefits of Camgenium’s tailored clinical audit reports include:

• Risk-adjusted comparative performance analysis over time
• Benchmarking against national datasets
• Clear identification of variation and opportunities for improvement

Reports are presented in a clear, easy-to-understand format to support structured review, strengthen clinical governance, and make performance variation transparent and actionable.

All data handling and analytics comply with stringent healthcare regulatory requirements. Camgenium’s software is HIPAA and GDPR ready, and ISO 13485 and ISO 27001 certified. This ensures robust data protection, patient confidentiality and full legal compliance across all services.

For more information, visit: https://www.camgenium.com/hospital-products

ENDS

For further information, please contact:

Camgenium
Lucy Turner, Marketing & Communications Manager  
E: lucy.turner@camgenium.com

​

Sciad Communications, Media Relations
Jasmin Shearan, Senior Account Manager
E: pressteam@sciad.com
T:+442034057892

Notes for Editors

About Camgenium

Camgenium specialises in the rapid development and deployment of regulatory compliant medical AI models, software and connected hardware medical devices.

Established in 2007, Camgenium has a reputation for regulatory excellence, working to standards including ISO 13485, ISO 27001, GxP and the NHS Data Security & Protection Toolkit.  

Camgenium has developed market-leading AI solutions derived from >100m global healthcare records as well as software products that have been deployed worldwide to tens of thousands of patients. Camgenium is certified by the NHS to access national data sets for development of AI and ML algorithms.  

The company has developed proprietary technology to accelerate development and has world-class medical hosting facilities in the UK, also servicing Europe and the USA.    

Cambridge based Camgenium has a client-centric approach, offering a complete service model from initial product concept through development, production, and deployment to decommissioning. The company can take regulatory responsibility for the whole product lifecycle and can deploy globally.  

Camgenium has assembled a best-in-class expert team of engineers, scientists and mathematicians. The team’s commitment to engineering excellence is demonstrated by its pro bono work teaching medical device design to students at Cambridge University Engineering Department, educating the next generation of medical device engineers.    

Camgenium is the trading name of L2S2 Ltd.  

To discover more about Camgenium, please visit www.camgenium.com.

​